Intellia Therapeutics Inc (NASDAQ:NTLA)

34.00
Delayed Data
As of Sep 20
 -0.38 / -1.11%
Today’s Change
32.44
Today|||52-Week Range
65.12
-2.55%
Year-to-Date

Today’s Trading

Previous close34.37
Today’s open34.68
Day’s range33.88 - 34.94
Volume801,899
Average volume (3 months)880,299
Market cap$3.2B
Data as of 3:59pm ET, 09/20/2023

Growth & Valuation

Earnings growth (last year)-63.03%
Earnings growth (this year)+13.84%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+57.69%
P/E ratioNM
Price/Sales51.53
Price/Book2.53

Competitors

 Today’s
change
Today’s
% change
DNLIDenali Therapeutics ...+0.13+0.59%
BPMCBlueprint Medicines ...-0.76-1.48%
----
ARWRArrowhead Pharmaceut...-0.22-0.81%
Data as of 4:00pm ET, 09/20/2023

Financials

Next reporting dateNovember 2, 2023
EPS forecast (this quarter)-$1.38
Annual revenue (last year)$52.1M
Annual profit (last year)-$474.2M
Net profit margin-909.78%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts